Kausalya Chennapragada Bhaskarabhatla, MD
Internal Medicine · Brentwood
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
Offices
2 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Bhaskarabhatla’s office at (415) 600-1020 to ask if they take your plan before you enroll.
Checkups this office reported
16 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
| Appropriate Treatment for Upper Respiratory Infection (URI)As Medicare defines this measure | 93% | 123 |
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 41%That's less than half. | 409 |
| Blood pressure under controlPeople with high blood pressure whose reading was in a healthy range | 63%That's more than half. | 134 |
| Breast cancer screeningEligible women who got a mammogram | 58%That's more than half. | 88 |
| Cervical cancer screeningEligible women who got a Pap or HPV test | 4%That's few of the people this applied to. | 200 |
| Checked for fall riskOlder patients screened for fall risk | 19%That's few of the people this applied to. | 68 |
| Closing the Referral Loop: Receipt of Specialist ReportAs Medicare defines this measure | 1% | 249 |
| Depression screeningPatients screened for depression, with a follow-up plan if needed | 1%That's few of the people this applied to. | 372 |
See the other 8 measures
| Diabetes eye examPeople with diabetes who got a retinal eye exam | 2%That's few of the people this applied to. | 96 |
| Diabetes poorly controlledPeople with diabetes whose blood sugar stayed very high | 31%That's less than half. Better on this measure. | 96 |
| HIV screeningEligible patients who were screened for HIV | 16%That's few of the people this applied to. | 370 |
| Medications listed in the chartVisits where the current medication list was documented | 54%That's more than half. | 2,132 |
| Risky medications in older adultsOlder patients given a medication that is risky at their age | 0%That's few of the people this applied to. Better on this measure. | 77 |
| Screening for High Blood Pressure and Follow-Up DocumentedAs Medicare defines this measure | 20% | 608 |
| Statin prescribed when it protects the heartPeople at cardiovascular risk who were prescribed a statin | 86%That's most of the people this applied to. | 121 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 50%That's more than half. | 337 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Depression screening
- Implementation of fall screening and assessment programs
- Implementation of medication management practice improvements
- Improved the patient portal
- Lets patients read their visit notes
- Tobacco use
- Uses standard treatment protocols
Original Medicare doctor bills
$8,309
Medicare paid this office $8,309 for 31 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 24 | $4,959 | $79 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 18 | $489 | $14 |
Who their Medicare patients are
31 Original Medicare patients in 2024. Average age 69 · Women 48% · Health risk score 0.95. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 74% · Diabetes 52%.
The office billed $18,775, Medicare allowed $11,715 and paid $8,309; for 121 services of 7 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 31 | 121 | 69 | 0.95 | $18,775 | $8,309 |
| 2023 | 28 | 114 | 70 | 1.11 | $22,650 | $9,296 |
| 2022 | 34 | 136 | 69 | 0.94 | $27,250 | $10,626 |
| 2021 | 36 | 119 | 69 | 1.20 | $24,100 | $10,139 |
| 2017 | 30 | 67 | 69 | 0.86 | $6,716 | $2,907 |
| 2016 | 73 | 146 | 69 | 1.11 | $19,573 | $8,962 |
| 2015 | 95 | 99 | 80 | 3.43 | $66,119 | $9,751 |
| 2014 | 161 | 168 | 80 | 2.63 | $88,491 | $12,937 |
| 2013 | 223 | 233 | 81 | 2.66 | $132,808 | $18,544 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Return visit (30+ min) | 26 | $7,152 | $79 |
2022: 1 service
| Return visit (30+ min) | 32 | $9,679 | $79 |
2021: 1 service
| Return visit (30+ min) | 34 | $8,296 | $85 |
2017: 1 service
| New patient visit (30+ min) | 11 | $394 | $36 |
2016: 3 services
| Return visit (30+ min) | 27 | $2,716 | $88 |
| New patient visit (30+ min) | 25 | $1,935 | $77 |
| New patient visit (45+ min) | 13 | $1,287 | $99 |
2015: 4 services
| Critical care, first 30-74 minutes | 39 | $7,195 | $184 |
| Hospital discharge day management, 30 minutes or less | 21 | $1,107 | $53 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $366 | $33 |
| Insertion of needle into vein (3 years or older) | 16 | $114 | $7 |
2014: 5 services
| Critical care, first 30-74 minutes | 43 | $7,454 | $169 |
| Hospital discharge day management, 30 minutes or less | 34 | $2,114 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $982 | $58 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 22 | $593 | $27 |
| Insertion of needle into vein (3 years or older) | 35 | $282 | $8 |
2013: 5 services
| Critical care, first 30-74 minutes | 75 | $12,856 | $171 |
| Hospital discharge day management, 30 minutes or less | 40 | $2,310 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $1,376 | $60 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 34 | $1,045 | $31 |
| Insertion of needle into vein (3 years or older) | 55 | $444 | $8 |
Medicaid work
$86,131 in 2024
Medicaid paid $86,131 for 876 billed services this clinician did in 2024, up to 87 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 876 | $86,131 |
| 2024 | 876 | 1 | 87 | $86,131 |
| 2023 | 1,538 | 3 | 102 | $147,257 |
| 2022 | 1,884 | 2 | 118 | $189,536 |
| 2021 | 964 | 2 | 90 | $99,916 |
| 2020 | 752 | 3 | 60 | $71,986 |
| 2019 | 863 | 4 | 45 | $91,480 |
| 2018 | 637 | 2 | 51 | $61,120 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 1,272 | $125,617 |
| Short return visit (20+ min) | 254 | $20,193 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 40-64 years | 12 | $1,447 |
2022
| Return visit (30+ min) | 1,759 | $179,591 |
| Short return visit (20+ min) | 125 | $9,945 |
2021
| Return visit (30+ min) | 947 | $98,470 |
| Short return visit (20+ min) | 17 | $1,446 |
2020
| Return visit (30+ min) | 500 | $49,906 |
| Short return visit (20+ min) | 185 | $12,884 |
| Long return visit (40+ min) | 67 | $9,197 |
2019
| Return visit (30+ min) | 552 | $56,811 |
| Long return visit (40+ min) | 183 | $24,587 |
| Preventive medicine counseling and risk factor reduction intervention for individual, approximately 45 minutes | 116 | $9,395 |
| Preventive medicine counseling and risk factor reduction intervention for individual, approximately 30 minutes | 12 | $687 |
2018
| Return visit (30+ min) | 486 | $49,098 |
| Preventive medicine counseling and risk factor reduction intervention for individual, approximately 45 minutes | 151 | $12,022 |
Drugs they prescribed that Part D paid
$61,967
Pharmacies billed $61,967 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
830 generic and 106 brand-name prescriptions · $61,967 in drug cost · 30 antibiotic prescriptions to 13 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Janumet | 12 | $10,963 | $914 |
| Jardiance | 15 | $9,912 | $661 |
| Diclofenac | 21 | $2,040 | $97 |
| Albuterol Sulfate Hfa | 28 | $858 | $31 |
| Candesartan Cilexetil | 12 | $596 | $50 |
See all 23 drugs
| Janumet | 12 | $10,963 | $914 |
| Jardiance | 15 | $9,912 | $661 |
| Diclofenac | 21 | $2,040 | $97 |
| Albuterol Sulfate Hfa | 28 | $858 | $31 |
| Candesartan Cilexetil | 12 | $596 | $50 |
| Atorvastatin | 79 | $572 | $7 |
| Acarbose | 12 | $542 | $45 |
| Rosuvastatin | 42 | $442 | $11 |
| Metoprolol | 29 | $405 | $14 |
| Atenolol-Chlorthalidone | 12 | $394 | $33 |
| Metformin | 93 | $365 | $4 |
| Fluticasone Propionate | 27 | $343 | $13 |
| Pantoprazole | 29 | $286 | $10 |
| Gabapentin | 21 | $241 | $11 |
| Tamsulosin | 15 | $236 | $16 |
| Levothyroxine | 47 | $220 | $5 |
| Lisinopril | 21 | $176 | $8 |
| Amlodipine Besylate | 43 | $151 | $4 |
| Losartan | 24 | $139 | $6 |
| Amoxicillin-Clavulanate Potass | 12 | $99 | $8 |
| Triamcinolone Acetonide | 13 | $89 | $7 |
| Carvedilol | 12 | $17 | $1 |
| Sertraline | 11 | $17 | $2 |
Year by year
| 2024 | 952 | 71 | None | 11% | $61,967 |
| 2023 | 854 | 80 | None | None | $50,129 |
| 2022 | 795 | 78 | None | None | $51,489 |
| 2021 | 492 | 53 | 0% (0) | None | $27,129 |
| 2020 | 500 | 69 | None | None | $35,363 |
| 2019 | 409 | 62 | None | None | $19,259 |
| 2018 | 316 | 51 | None | None | $9,612 |
| 2017 | 254 | 51 | None | 20% | $12,548 |
| 2016 | 89 | 52 | 0% (0) | 27% | $3,783 |
| 2015 | 45 | 16 | 0% (0) | None | $1,050 |
| 2014 | 86 | 17 | None | 33% | $5,748 |
| 2013 | 27 | 13 | None | 44% | $1,817 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 20 drugs
| Albuterol Sulfate Hfa | 28 | $1,054 | $38 |
| Atorvastatin | 59 | $967 | $16 |
| Rosuvastatin | 44 | $956 | $22 |
| Amlodipine Besylate | 47 | $709 | $15 |
| Levothyroxine | 44 | $565 | $13 |
| Gabapentin | 30 | $478 | $16 |
| Acarbose | 14 | $419 | $30 |
| Diclofenac | 19 | $401 | $21 |
| Lisinopril | 26 | $354 | $14 |
| Metformin | 70 | $313 | $4 |
| Fluticasone Propionate | 16 | $300 | $19 |
| Metoprolol | 17 | $280 | $16 |
| Pantoprazole | 19 | $276 | $15 |
| Losartan | 20 | $260 | $13 |
| Carvedilol | 11 | $150 | $14 |
| Omeprazole | 11 | $133 | $12 |
| Hydrochlorothiazide | 19 | $101 | $5 |
| Azithromycin | 11 | $95 | $9 |
| Metoprolol | 13 | $86 | $7 |
| Naproxen | 12 | $44 | $4 |
2022: 17 drugs
| Rosuvastatin | 37 | $2,555 | $69 |
| Albuterol Sulfate Hfa | 26 | $983 | $38 |
| Atorvastatin | 57 | $703 | $12 |
| Levothyroxine | 55 | $608 | $11 |
| Metoprolol | 11 | $440 | $40 |
| Diclofenac | 21 | $420 | $20 |
| Amlodipine Besylate | 40 | $342 | $9 |
| Metformin | 66 | $319 | $5 |
| Candesartan Cilexetil | 13 | $288 | $22 |
| Gabapentin | 24 | $254 | $11 |
| Lisinopril | 29 | $252 | $9 |
| Tamsulosin | 11 | $245 | $22 |
| Fluticasone Propionate | 20 | $185 | $9 |
| Omeprazole | 17 | $178 | $10 |
| Losartan | 22 | $162 | $7 |
| Amoxicillin-Clavulanate Potass | 12 | $143 | $12 |
| Metoprolol | 14 | $78 | $6 |
2021: 15 drugs
| Rosuvastatin | 16 | $775 | $48 |
| Albuterol Sulfate Hfa | 14 | $685 | $49 |
| Metoprolol | 16 | $611 | $38 |
| Atorvastatin | 40 | $542 | $14 |
| Diclofenac | 22 | $331 | $15 |
| Levothyroxine | 16 | $294 | $18 |
| Gabapentin | 19 | $232 | $12 |
| Amlodipine Besylate | 29 | $191 | $7 |
| Metformin | 30 | $175 | $6 |
| Fluticasone Propionate | 12 | $175 | $15 |
| Losartan | 16 | $150 | $9 |
| Famotidine | 11 | $117 | $11 |
| Atenolol-Chlorthalidone | 11 | $110 | $10 |
| Lisinopril | 19 | $93 | $5 |
| Metoprolol | 15 | $40 | $3 |
2020: 14 drugs
| Breo Ellipta | 11 | $5,545 | $504 |
| Albuterol Sulfate Hfa | 13 | $625 | $48 |
| Rosuvastatin | 14 | $523 | $37 |
| Atorvastatin | 48 | $447 | $9 |
| Levothyroxine | 13 | $276 | $21 |
| Diclofenac | 11 | $194 | $18 |
| Gabapentin | 22 | $172 | $8 |
| Metoprolol | 14 | $150 | $11 |
| Amlodipine Besylate | 25 | $129 | $5 |
| Levocetirizine Dihydrochloride | 12 | $122 | $10 |
| Losartan | 20 | $118 | $6 |
| Metformin | 28 | $93 | $3 |
| Famotidine | 18 | $89 | $5 |
| Lisinopril | 19 | $64 | $3 |
2019: 9 drugs
| Atorvastatin | 38 | $509 | $13 |
| Levothyroxine | 16 | $352 | $22 |
| Metformin | 26 | $134 | $5 |
| Omeprazole | 12 | $131 | $11 |
| Ranitidine | 11 | $113 | $10 |
| Pantoprazole | 11 | $110 | $10 |
| Lisinopril | 15 | $82 | $5 |
| Losartan | 14 | $61 | $4 |
| Hydrochlorothiazide | 11 | $39 | $4 |
2018: 6 drugs
| Atorvastatin | 29 | $259 | $9 |
| Ranitidine | 30 | $240 | $8 |
| Gabapentin | 17 | $187 | $11 |
| Losartan | 20 | $94 | $5 |
| Lisinopril | 12 | $64 | $5 |
| Metformin | 12 | $64 | $5 |
2017: 6 drugs
| Proair Hfa | 13 | $728 | $56 |
| Atorvastatin | 24 | $454 | $19 |
| Levothyroxine | 14 | $262 | $19 |
| Losartan | 20 | $129 | $6 |
| Metformin | 17 | $100 | $6 |
| Ranitidine | 11 | $73 | $7 |
Money from drug and device companies
$21 in 2022
A payment is not proof that care is biased.
| E.R. Squibb & Sons L.L.C. | Eliquis | $21 | 1 payment
|
See the published payment
| E.R. Squibb & Sons L.L.C. | Meals · 2022-02-15 | Eliquis | $21 |
Professional record
- NPI
- 1003867607
- Licence
- NJ MAO71431
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 4501 Sand Creek Rd, Antioch, CA, 94531
- NPI first listed
- 2006-05-16
- NPI last updated
- 2026-03-19
- NPI record certified
- 2026-03-19
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 350 John Muir Pkwy, Brentwood, CA, 94513